Sarah Jane Tribble

Trump adds a global pricing plan to wide attack on drug prices, but doubts persist Sarah Jane Tribble
Unwitting patients, copycat comments play hidden role in federal rule-making Sarah Jane Tribble
How a drugmaker turned the abortion pill into a rare-disease profit machine Sarah Jane Tribble
FDA head vows to tackle high drug prices and drugmakers "gaming the system" Sarah Jane Tribble
Trump’s budget proposal swings at drug prices with a glancing blow Sarah Jane Tribble
FDA Chief open to rethinking incentives on orphan drugs Sarah Jane Tribble
Experts tell Congress how to cut drug prices. We give you some odds Sarah Jane Tribble
Will Medicare patients get a cut of prescription deals? Sarah Jane Tribble
Drug rebates reward industry players — and often hurt patients Sarah Jane Tribble
A major drug company left its lobbying group over a drug price controversy Sarah Jane Tribble
Big pharma is "getting away with murder": Drugmakers help turn patients with rare diseases into D.C. lobbyists Sarah Jane Tribble
GAO to launch investigation of FDA’s Orphan Drug Program Sarah Jane Tribble
Page: 1